
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis
Natasha Bush, Logan K. Townsend, David C. Wright
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 3, pp. 526-535
Open Access | Times Cited: 21
Natasha Bush, Logan K. Townsend, David C. Wright
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 3, pp. 526-535
Open Access | Times Cited: 21
Showing 21 citing articles:
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients
Marco Pozzi, Chiara Vantaggiato, F Brivio, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Marco Pozzi, Chiara Vantaggiato, F Brivio, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 40
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 40
AMPK mediates energetic stress‐induced liver GDF15
Logan K. Townsend, Alyssa J. Weber, Emily A. Day, et al.
The FASEB Journal (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 32
Logan K. Townsend, Alyssa J. Weber, Emily A. Day, et al.
The FASEB Journal (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 32
Francis Ramond, Marlène Rio, Bénédicte Héron, et al.
Journal of Inherited Metabolic Disease (2020) Vol. 43, Iss. 6, pp. 1254-1264
Closed Access | Times Cited: 28
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
Heidi N. Boyda, Amanzo A. Ho, Lurdes Tse, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
Heidi N. Boyda, Amanzo A. Ho, Lurdes Tse, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
AMPK β1 activation suppresses antipsychotic‐induced hyperglycemia in mice
Hesham Shamshoum, Kyle D. Medak, Logan K. Townsend, et al.
The FASEB Journal (2019) Vol. 33, Iss. 12, pp. 14010-14021
Open Access | Times Cited: 20
Hesham Shamshoum, Kyle D. Medak, Logan K. Townsend, et al.
The FASEB Journal (2019) Vol. 33, Iss. 12, pp. 14010-14021
Open Access | Times Cited: 20
GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia
Kyle D. Medak, Hesham Shamshoum, Willem T. Peppler, et al.
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 6, pp. E1101-E1111
Closed Access | Times Cited: 15
Kyle D. Medak, Hesham Shamshoum, Willem T. Peppler, et al.
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 6, pp. E1101-E1111
Closed Access | Times Cited: 15
Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches
Hesham Shamshoum, Kyle D. Medak, David C. Wright
Behavioural Brain Research (2020) Vol. 400, pp. 113049-113049
Closed Access | Times Cited: 15
Hesham Shamshoum, Kyle D. Medak, David C. Wright
Behavioural Brain Research (2020) Vol. 400, pp. 113049-113049
Closed Access | Times Cited: 15
Fasting or the short‐term consumption of a ketogenic diet protects against antipsychotic‐induced hyperglycaemia in mice
Hesham Shamshoum, Kyle D. Medak, Greg L. McKie, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 11, pp. 2713-2728
Closed Access | Times Cited: 9
Hesham Shamshoum, Kyle D. Medak, Greg L. McKie, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 11, pp. 2713-2728
Closed Access | Times Cited: 9
Carnosic acid prevented olanzapine-induced metabolic disorders through AMPK activation
Bibi Marjan Razavi, Amir Reza Abazari, Maryam Rameshrad, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 10, pp. 7583-7592
Closed Access | Times Cited: 12
Bibi Marjan Razavi, Amir Reza Abazari, Maryam Rameshrad, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 10, pp. 7583-7592
Closed Access | Times Cited: 12
A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models
Jessica W. Y. Yuen, Che Hsuan David Wu, Catherine K. Wang, et al.
Neuropharmacology (2019) Vol. 175, pp. 107717-107717
Closed Access | Times Cited: 11
Jessica W. Y. Yuen, Che Hsuan David Wu, Catherine K. Wang, et al.
Neuropharmacology (2019) Vol. 175, pp. 107717-107717
Closed Access | Times Cited: 11
Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats
Ching-Ping Yang, Yayu Wang, Shih‐Yi Lin, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 640-640
Open Access | Times Cited: 10
Ching-Ping Yang, Yayu Wang, Shih‐Yi Lin, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 640-640
Open Access | Times Cited: 10
A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0246211-e0246211
Open Access | Times Cited: 9
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0246211-e0246211
Open Access | Times Cited: 9
Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
Heidi N. Boyda, Michelle Pham, Joyce Y. Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Heidi N. Boyda, Michelle Pham, Joyce Y. Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control
Christian Carpéné, Francisco Les, Josep Mercader, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 3, pp. 41-41
Open Access | Times Cited: 6
Christian Carpéné, Francisco Les, Josep Mercader, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 3, pp. 41-41
Open Access | Times Cited: 6
Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
Kyle D. Medak, Alyssa J. Weber, Hesham Shamshoum, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Kyle D. Medak, Alyssa J. Weber, Hesham Shamshoum, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance
Jessica W. Y. Yuen, Claire Wu, Cathy K. Wang, et al.
Psychoneuroendocrinology (2021) Vol. 129, pp. 105257-105257
Closed Access | Times Cited: 4
Jessica W. Y. Yuen, Claire Wu, Cathy K. Wang, et al.
Psychoneuroendocrinology (2021) Vol. 129, pp. 105257-105257
Closed Access | Times Cited: 4
Antipsychotic-induced dysregulation of glucose metabolism through the central nervous system: a scoping review of animal models
Emily Au, Kristoffer Panganiban, Sally Wu, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 10, Iss. 3, pp. 244-257
Closed Access
Emily Au, Kristoffer Panganiban, Sally Wu, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 10, Iss. 3, pp. 244-257
Closed Access
Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine
Kyle D. Medak, Stewart Jeromson, A. Bellucci, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108628-108628
Open Access
Kyle D. Medak, Stewart Jeromson, A. Bellucci, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108628-108628
Open Access